Parathyroid hormone alleviates non-alcoholic liver steatosis via activating the hepatic cAMP/PKA/CREB pathway

Non-alcoholic fatty liver disease (NAFLD), hallmarked by liver steatosis, is becoming a global concern, but effective and safe drugs for NAFLD are still lacking at present. Parathyroid hormone (PTH), the only FDA-approved anabolic treatment for osteoporosis, is important in calcium-phosphate homeost...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xu, Xiao, Ye, Guo, Qi, Peng, Hui, Zhou, Hai-Yan, Wang, Jian-Ping, Xia, Zhu-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428460/
https://www.ncbi.nlm.nih.gov/pubmed/36060945
http://dx.doi.org/10.3389/fendo.2022.899731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428460/
https://www.ncbi.nlm.nih.gov/pubmed/36060945
http://dx.doi.org/10.3389/fendo.2022.899731

Ejemplares similares